Clinical Trials on Renal Clear Cell Carcinoma
Total 12330 results
-
Nanfang Hospital, Southern Medical UniversityRecruitingClear-cell Metastatic Renal Cell CarcinomaChina
-
Arcus Biosciences, Inc.RecruitingClear Cell Renal Cell Carcinoma | Solid TumorsKorea, Republic of, United States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingRenal Cell Carcinoma, Clear Cell, SomaticAustralia
-
M.D. Anderson Cancer CenterPfizerCompleted
-
Mirati Therapeutics Inc.CompletedClear Cell Renal Cell CarcinomaUnited States
-
ExelixisRecruitingNon-Clear Cell Renal Cell CarcinomaUnited States, Spain, Korea, Republic of, Italy, Australia, France, Argentina, Brazil, Chile, Czechia, Finland, Germany, Malaysia, Netherlands, Poland, Thailand
-
Xencor, Inc.RecruitingClear Cell Renal Cell CarcinomaUnited States
-
Bristol-Myers SquibbRecruitingClear Cell Renal Cell CarcinomaRussian Federation, New Zealand, United States, Finland, France, Ireland, Italy, Turkey, Poland, Argentina, Brazil, Chile, Czechia, Mexico, Portugal, Romania, Spain
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingClear Cell Renal Cell CarcinomaFrance
-
Telix Pharmaceuticals (Innovations) Pty LimitedAvailable
-
Lawson Health Research InstituteHamilton Health Sciences Corporation; London Health Sciences CentreCompletedClear Cell Renal Cancer | Circulating Tumor Cells | Predictive Biomarkers | Prognostic Biomarkers | Circulating Endothelial CellsCanada
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.CompletedKidney CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States
-
National Taiwan University HospitalSamsung Medical Center; Chang Gung Memorial Hospital; Tokyo UniversityNot yet recruitingFIGO Stage IC2 to II Ovarian Clear Cell Carcinoma
-
Barretos Cancer HospitalCompletedKidney Cancer | Biomarkers | Gene ExpressionBrazil
-
RenJi HospitalNot yet recruitingImmune Checkpoint Inhibitors | Clear-cell Metastatic Renal Cell Carcinoma | Cytoreductive Nephrectomy
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellPoland, Australia, Japan, United States, Korea, Republic of, Taiwan, China, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Malaysia, Mexico, Netherlands, New Zealand, Romani... and more
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruiting
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Janssen Research & Development, LLCActive, not recruitingClear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Bladder Urothelial Carcinoma | Metastatic Kidney Carcinoma | Malignant Urinary System NeoplasmUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingRenal Cell Carcinoma
-
Peloton Therapeutics, Inc., a subsidiary of Merck...Active, not recruitingKidney Cancer | Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | ccRCC | RCCUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, Renal CellUnited States, Colombia, Canada, Australia, Finland, Japan, United Kingdom, Brazil, Chile, China, Croatia, Czechia, Denmark, France, Germany, Guatemala, Hungary, Ireland, Italy, Korea, Republic of, Malaysia, Mexico, Norway, Philippines, Polan... and more
-
Aravive, Inc.TerminatedClear Cell Renal Cell CarcinomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellUnited States
-
NHS Greater Glasgow and ClydeBoehringer Ingelheim; Cancer Research UK; European Organisation for Research... and other collaboratorsUnknownOvarian Clear Cell Carcinoma | Endometrial Clear Cell CarcinomaUnited Kingdom
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingKidney Cancer | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8United States
-
Elizabeth K. Lee MDMerck Sharp & Dohme LLCRecruitingGynecologic Cancer | Ovarian Clear Cell CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyTerminatedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Recurrent Uterine Corpus CancerUnited States
-
Ohio State University Comprehensive Cancer CenterBayer; NovartisCompletedMelanoma | Renal CancerUnited States
-
Peking Union Medical College HospitalRecruitingClear Cell Renal Cell CarcinomaChina
-
First Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)WithdrawnClear Cell Renal Cell Carcinoma | Rhabdoid Tumor of the Kidney | Congenital Mesoblastic Nephroma | Childhood Kidney NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Clear Cell Renal Cell Carcinoma | Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Metastatic Urothelial Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage... and other conditionsUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Not yet recruitingUrothelial Carcinoma | Metastatic Castration-resistant Prostate Cancer | Clear Cell Renal CarcinomaChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Mixed Adenocarcinoma | Endometrial...United States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Mixed Adenocarcinoma | Endometrial...United States
-
Nuvectis Pharma, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingOvarian Cancer | Ovarian Endometrioid Adenocarcinoma | Advanced Solid Tumor | Ovarian Clear Cell Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Clear Cell Tumor | Ovarian Endometrioid Tumor | ARID1A Gene MutationUnited States, United Kingdom
-
Calithera Biosciences, IncTerminatedClear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCCUnited States
-
Association Pour La Recherche des Thérapeutiques...UnknownBone Metastases | Clear-cell Metastatic Renal Cell CarcinomaFrance
-
National Cancer Institute (NCI)Active, not recruitingClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Lymph Nodes | Metastatic Malignant Neoplasm in the Soft Tissues | Metastatic Malignant Neoplasm in the Viscera and other conditionsUnited States, Puerto Rico
-
Oslo University HospitalRecruitingClear Cell Renal Cell Carcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Melanoma Stage IV | Cutaneous Squamous Cell Carcinoma | MSI-HighNorway
-
Bristol-Myers SquibbCompletedRenal Cell Carcinoma | Non-hodgkin's LymphomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell Carcinoma | Malignant Uterine Corpus Mixed Epithelial and Mesenchymal NeoplasmUnited States
-
Australian and New Zealand Urogenital and Prostate...RecruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11.2 Translocation-Related Renal Cell CarcinomaAustralia
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Renal Cell Carcinoma | Metastatic Melanoma | Advanced Locoregional Melanoma | Clear Cell HistologyUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Endometrial Clear Cell Carcinoma | Endometrial Papillary Serous Carcinoma | Endometrial Adenosquamous Cell Carcinoma | Endometrial AdenoacanthomaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingAdvanced Non-Clear Cell Kidney CancerUnited States
-
Bradley A. McGregor, MDBristol-Myers Squibb; ExelixisRecruitingRenal Cell Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Unclassified Renal Cell Carcinoma | Collecting Duct Renal Cell Carcinoma | Translocation Renal Cell Carcinoma | Unresectable Advanced Renal Cell Carcinoma | Metastatic Ncc Renal Cell CarcinomaUnited States